Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by V. D. Fedorov
PD-1- And CTLA-4-Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses
Science Translational Medicine
Medicine
Related publications
Intestinal Microbiota Predict Response and Toxicities During Anti-Pd-1/Anti-Ctla-4 Immunotherapy
Pathology
Forensic Medicine
Pathology
CTLA4 Methylation Predicts Response to Anti–PD-1 and Anti–CTLA-4 Immunotherapy in Melanoma Patients
JCI insight
Medicine
Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions
Journal of Gene Medicine
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
214. Design of Multifunctional Chimeric Antigen Receptors for T Cell Cancer Immunotherapy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers
International Journal of Endocrinology
Endocrine
Endocrinology
Metabolism
Autonomic Systems
Diabetes
The Other Face of Chimeric Antigen Receptors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Total Costs of Chimeric Antigen Receptor T-Cell Immunotherapy
JAMA Oncology
Cancer Research
Oncology
Engineering HIV-Specific Immunity With Chimeric Antigen Receptors
AIDS Patient Care and STDs
Environmental
Public Health
Infectious Diseases
Occupational Health
The Efficacy and Safety of Combination of PD-1 and CTLA-4 Inhibitors: A Meta-Analysis
Experimental Hematology and Oncology
Cancer Research
Oncology
Hematology